Elevation Oncology, Inc. (ELEV)
0.3650
-0.0079 (-2.12%)
Inactive · Last trade price on Jul 22, 2025
Elevation Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 60.49 | 49.46 | 49.26 | 45.92 | 146.28 | 79.4 |
Short-Term Investments | 20.17 | 43.72 | 33.85 | 44.36 | - | - |
Cash & Short-Term Investments | 80.66 | 93.18 | 83.11 | 90.28 | 146.28 | 79.4 |
Cash Growth | -22.48% | 12.13% | -7.95% | -38.28% | 84.24% | 4463.22% |
Prepaid Expenses | 1.54 | 1.54 | 4.86 | 2.7 | 3.14 | 1.39 |
Total Current Assets | 82.19 | 94.73 | 87.96 | 92.98 | 149.42 | 80.79 |
Property, Plant & Equipment | 0.03 | 0.03 | 0.06 | - | - | - |
Other Intangible Assets | - | - | - | 0.1 | 0.04 | 0.06 |
Other Long-Term Assets | - | 0.87 | 1.07 | 1.09 | 0.03 | 0.07 |
Total Assets | 82.22 | 95.63 | 89.09 | 94.16 | 149.49 | 80.91 |
Liabilities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Accounts Payable | 0.49 | 0.56 | 0.51 | 6.36 | 5.65 | 5.68 |
Accrued Expenses | 1.58 | 3.91 | 3.64 | 9.33 | 3.14 | 1.11 |
Other Current Liabilities | 2.17 | - | 0 | - | - | - |
Total Current Liabilities | 4.24 | 4.47 | 4.14 | 15.69 | 8.79 | 6.79 |
Long-Term Debt | 31.25 | 31.13 | 30.14 | 29.44 | - | - |
Other Long-Term Liabilities | - | - | - | 0 | 0.01 | 0.02 |
Total Liabilities | 35.49 | 35.6 | 34.28 | 45.13 | 8.8 | 6.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | - |
Additional Paid-In Capital | 301.51 | 300.52 | 250.83 | 199.49 | 195.88 | 0.07 |
Retained Earnings | -254.67 | -240.46 | -195.97 | -150.27 | -55.19 | -23.15 |
Treasury Stock | -0.12 | -0.11 | -0.06 | -0.04 | - | - |
Comprehensive Income & Other | 0.01 | 0.06 | 0.01 | -0.16 | - | - |
Total Common Equity | 46.73 | 60.03 | 54.81 | 49.03 | 140.7 | -23.08 |
Shareholders' Equity | 46.73 | 60.03 | 54.81 | 49.03 | 140.7 | 74.11 |
Total Liabilities & Equity | 82.22 | 95.63 | 89.09 | 94.16 | 149.49 | 80.91 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Total Debt | 31.25 | 31.13 | 30.14 | 29.44 | - | - |
Net Cash (Debt) | 49.41 | 62.05 | 52.97 | 60.85 | 146.28 | 79.4 |
Net Cash Growth | -32.54% | 17.14% | -12.94% | -58.41% | 84.24% | 4463.22% |
Net Cash Per Share | 0.84 | 1.08 | 1.45 | 2.62 | 12.06 | 100.28 |
Filing Date Shares Outstanding | 59.22 | 59.22 | 48.65 | 23.66 | 23.21 | 0.8 |
Total Common Shares Outstanding | 59.22 | 59.13 | 42.42 | 23.29 | 23.21 | 0.8 |
Working Capital | 77.96 | 90.26 | 83.82 | 77.29 | 140.64 | 74 |
Book Value Per Share | 0.79 | 1.02 | 1.29 | 2.11 | 6.06 | -28.83 |
Tangible Book Value | 46.73 | 60.03 | 54.81 | 48.93 | 140.66 | -23.14 |
Tangible Book Value Per Share | 0.79 | 1.02 | 1.29 | 2.10 | 6.06 | -28.90 |